Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici, A.; Emet, SAMİM; Cakmak, R.; YURUYEN, G.; Alibeyoglu, Alpay; AKARSU, M.; ARMAN, Yusuf; Kose, M.; OZGUN, Ersin; OZCAN, M.; ALTUN, O.; Onur, I.; Tukek, TUFAN

doi:10.26355/eurrev_201806_15180

Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.

Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., ...More

European review for medical and pharmacological sciences, vol.22, no.11, pp.3534-3543, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 22 Issue: 11
Publication Date: 2018
Doi Number: 10.26355/eurrev_201806_15180
Journal Name: European review for medical and pharmacological sciences
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.3534-3543
Istanbul University Affiliated: Yes

Abstract

OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS.